These findings implicate the retrotransposon-like activity of PEG10 as a contributing mechanism in ALS through the regulation of gene expression, and restraint of PEG10 as a primary function of UBQLN2. The gene discussed is UBQLN2; the disease is amyotrophic lateral sclerosis.